s6y BridgeBio Oncology Therapeutics, Inc. EFFECT

BridgeBio Oncology Therapeutics, Inc. EFFECT, filed May 4, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 4, 2026
Accession Number: 0001193125-26-197901
Submission Type: POS AM
CIK: 0001869105
Company Name: BridgeBio Oncology Therapeutics, Inc.
File Number: 333-289940